FIRST AMENDMENT TO SENIOR SECURED CONVERTIBLE NOTESecurities Purchase Agreement • October 25th, 2023 • Chromocell Therapeutics Corp • Biological products, (no disgnostic substances)
This First Amendment to Senior Secured Convertible Note (this “Amendment”) dated as of October 12, 2023 (the “Effective Date”) is entered into by and between Chromocell Therapeutics Corporation, a Delaware corporation (the “Company”), and the purchasers identified on the signature pages hereto (each, a “Purchaser” and together, the “Purchasers”).
SECOND AMENDMENT TO SENIOR SECURED CONVERTIBLE NOTESenior Secured Convertible Note • October 25th, 2023 • Chromocell Therapeutics Corp • Biological products, (no disgnostic substances)
This Second Amendment to Senior Secured Convertible Note (this “Amendment”) dated as of October 24, 2023 (the “Effective Date”) is entered into by and between Chromocell Therapeutics Corporation, a Delaware corporation (the “Company”), and the purchasers identified on the signature pages hereto (each, a “Purchaser” and together, the “Purchasers”).
